Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2005 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Retargeting T cells and immune effector cells with bispecific antibodies.
Cancer Chemother Biol Response Modif. 2005;22:273-91. doi: 10.1016/s0921-4410(04)22013-0.
Cancer Chemother Biol Response Modif. 2005.
PMID: 16110617
Review.
Anti-CD3 x anti-HER2 bispecific antibody effectively redirects armed T cells to inhibit tumor development and growth in hormone-refractory prostate cancer-bearing severe combined immunodeficient beige mice.
Davol PA, Smith JA, Kouttab N, Elfenbein GJ, Lum LG.
Davol PA, et al.
Clin Prostate Cancer. 2004 Sep;3(2):112-21. doi: 10.3816/cgc.2004.n.021.
Clin Prostate Cancer. 2004.
PMID: 15479495
Item in Clipboard
Cite
Cite